Clinicopathologic and Molecular Characteristics of and Diagnostic Dilemmas in Invasive Breast Carcinoma with Choriocarcinomatous Pattern apropos a New Case: A Literature Review with New Findings.
Breast cancer
Human chorionic gonadotropin
Invasive breast cancer with choriocarcinomatous pattern
PTEN
Sequencing
TP53
Journal
Pathobiology : journal of immunopathology, molecular and cellular biology
ISSN: 1423-0291
Titre abrégé: Pathobiology
Pays: Switzerland
ID NLM: 9007504
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
09
2021
accepted:
02
02
2022
pubmed:
31
3
2022
medline:
16
12
2022
entrez:
30
3
2022
Statut:
ppublish
Résumé
Invasive breast carcinoma with a choriocarcinomatous pattern (IBC-CP) is extremely rare, and its molecular basis is yet unclear. The choriocarcinomatous pattern is characterized by the biphasic arrangement of multinucleated syncytiotrophoblast-like cells around clusters of monotypic tumor cells in a hemorrhagic background, along with β-human chorionic gonadotropin (β-hCG) expression. The differentiation of IBC-CP from metastatic choriocarcinoma of the breast (MC-B) is difficult due to the histologic similarity. Based on a literature review and our own case, the clinicopathologic differences between IBC-CP patients (n = 17) and MC-B patients (n = 8) were analyzed. Moreover, in our case of IBC-CP, next-generation sequencing (NGS) comparative analysis was conducted for both choriocarcinomatous and invasive breast carcinoma (IBC) components. Compared to the MC-B patients, the IBC-CP patients were older (p < 0.001) and less frequently had past histories of gestational trophoblastic disease/pregnancy/abortion (p = 0.001) and distant metastases (p = 0.005). Our case, a 49-year-old female patient, presented with masses in the right breast and axilla. Following neoadjuvant chemotherapy, a radical mastectomy found an 8.5-cm-sized tumor. Microscopically, multinucleated syncytiotrophoblast-like cells were observed around mononuclear tumor cells with hemorrhage and necrosis. Some tumor cells showed β-hCG immunopositivity, which was compatible with IBC-CP. NGS results showed a missense mutation in exon 5 of the TP53 gene in both the choriocarcinomatous and IBC components. Meanwhile, copy number loss in the PTEN gene was only identified in the choriocarcinomatous components. The present IBC-CP case is triple-negative breast cancer with TP53 mutation. The PTEN gene may be associated with choriocarcinomatous differentiation. Obtaining a medical history is mandatory to exclude metastatic lesions.
Sections du résumé
BACKGROUND
BACKGROUND
Invasive breast carcinoma with a choriocarcinomatous pattern (IBC-CP) is extremely rare, and its molecular basis is yet unclear. The choriocarcinomatous pattern is characterized by the biphasic arrangement of multinucleated syncytiotrophoblast-like cells around clusters of monotypic tumor cells in a hemorrhagic background, along with β-human chorionic gonadotropin (β-hCG) expression. The differentiation of IBC-CP from metastatic choriocarcinoma of the breast (MC-B) is difficult due to the histologic similarity.
METHODS
METHODS
Based on a literature review and our own case, the clinicopathologic differences between IBC-CP patients (n = 17) and MC-B patients (n = 8) were analyzed. Moreover, in our case of IBC-CP, next-generation sequencing (NGS) comparative analysis was conducted for both choriocarcinomatous and invasive breast carcinoma (IBC) components.
RESULTS
RESULTS
Compared to the MC-B patients, the IBC-CP patients were older (p < 0.001) and less frequently had past histories of gestational trophoblastic disease/pregnancy/abortion (p = 0.001) and distant metastases (p = 0.005). Our case, a 49-year-old female patient, presented with masses in the right breast and axilla. Following neoadjuvant chemotherapy, a radical mastectomy found an 8.5-cm-sized tumor. Microscopically, multinucleated syncytiotrophoblast-like cells were observed around mononuclear tumor cells with hemorrhage and necrosis. Some tumor cells showed β-hCG immunopositivity, which was compatible with IBC-CP. NGS results showed a missense mutation in exon 5 of the TP53 gene in both the choriocarcinomatous and IBC components. Meanwhile, copy number loss in the PTEN gene was only identified in the choriocarcinomatous components.
CONCLUSION
CONCLUSIONS
The present IBC-CP case is triple-negative breast cancer with TP53 mutation. The PTEN gene may be associated with choriocarcinomatous differentiation. Obtaining a medical history is mandatory to exclude metastatic lesions.
Identifiants
pubmed: 35354152
pii: 000522621
doi: 10.1159/000522621
pmc: PMC9811418
doi:
Types de publication
Case Reports
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
359-369Informations de copyright
© 2022 The Author(s). Published by S. Karger AG, Basel.
Références
Eur J Surg Oncol. 1995 Oct;21(5):576-8
pubmed: 7589612
Clin Cancer Res. 2019 Jul 15;25(14):4516-4529
pubmed: 31010836
World J Surg Oncol. 2014 Jul 30;12:239
pubmed: 25073898
J Res Med Sci. 2011 May;16(5):707-11
pubmed: 22091297
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Pathobiology. 2021;88(3):228-233
pubmed: 33567441
Arch Pathol Lab Med. 2011 Sep;135(9):1097-100
pubmed: 21877993
AJR Am J Roentgenol. 2005 Mar;184(3 Suppl):S53-5
pubmed: 15728021
Dev Cell. 2005 Apr;8(4):467-77
pubmed: 15809030
J Breast Cancer. 2013 Sep;16(3):349-53
pubmed: 24155767
Hum Pathol. 2019 Mar;85:221-227
pubmed: 30468800
Histopathology. 2015 Nov;67(5):636-44
pubmed: 25753145
Acta Cytol. 1991 Mar-Apr;35(2):239-42
pubmed: 1709325
Pathol Oncol Res. 2018 Apr;24(2):259-267
pubmed: 28470571
Nat Protoc. 2015 Oct;10(10):1556-66
pubmed: 26379229
Histopathology. 1990 May;16(5):504-6
pubmed: 2163358
Sao Paulo Med J. 2001 Jul 5;119(4):154-5
pubmed: 11500791
Diagn Cytopathol. 2006 Oct;34(10):694-7
pubmed: 16955470
Neoplasia. 2015 Apr;17(4):385-99
pubmed: 25925381
Pathol Int. 1999 Sep;49(9):816-9
pubmed: 10504554
Am J Surg Pathol. 1981 Dec;5(8):773-8
pubmed: 6278975
Eur J Cancer Clin Oncol. 1984 May;20(5):679-84
pubmed: 6203754
Gynecol Oncol. 1981 Jun;11(3):348-63
pubmed: 7250760
Acta Cytol. 2004 Jan-Feb;48(1):91-4
pubmed: 14969189
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
pubmed: 27899578
Breast J. 2002 Jul-Aug;8(4):244-8
pubmed: 12100118
Ann Diagn Pathol. 2004 Apr;8(2):74-9
pubmed: 15060884
J Obstet Gynaecol India. 2012 Dec;62(Suppl 1):97-8
pubmed: 24293893
Int J Mol Sci. 2017 Jul 21;18(7):
pubmed: 28754015
Breast J. 2010 Mar-Apr;16(2):202-3
pubmed: 20465601
Acta Cytol. 2008 Jan-Feb;52(1):99-104
pubmed: 18323284
Gynecol Oncol. 1991 Dec;43(3):295-9
pubmed: 1661265